The most revealing comment about the BLA, IMO, was
Post# of 148184
What is the assay in question? Receptor occupancy seems like an obvious choice. Can that be done retroactively? I'm skeptical if it means rounding up former trial participants but maybe there is a workaround. I'd appreciate any thoughts on that.